Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2021 | Moving towards a cure for myeloma

Aurore Perrot • 9 Sep 2021
IMW 2021
Multiple Myeloma

Aurore Perrot, MD, of Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France, explains the progress made in the treatment for myeloma and talks on how the rate at which drugs are being developed, advances in measurable residual disease (MRD), and improved risk-adapted strategies, may enable patients with myeloma to be cured in the future. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.

More from Aurore Perrot

0:48
The role of transplant in myeloma
Aurore Perrot • 9 Sep 2021
2:23
Real-world data: treatment pathways for myeloma patients in France
Aurore Perrot • 9 Sep 2021
5:24
IFM 209 update: 4-year extended follow-up of transplantation outcomes in myeloma
Aurore Perrot • 7 Dec 2020
1:08
Long term follow-up results from the Phase III MAIA trial in myeloma
Aurore Perrot • 7 Dec 2020

Related Videos

1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
The content of VJHemOnc is intended for healthcare professionals